Recent AVTX News
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 08:01:41 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/29/2024 08:08:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 08:23:55 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 08:17:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/16/2024 11:36:46 AM
- Avalo Therapeutics Announces Appointment of Dr. Mittie Doyle as Chief Medical Officer • GlobeNewswire Inc. • 07/16/2024 11:00:00 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/11/2024 08:24:12 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 07/11/2024 08:12:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 11:17:21 AM
- Avalo Therapeutics Announces Appointment of Paul Varki as Chief Legal Officer • GlobeNewswire Inc. • 06/24/2024 08:01:00 PM
- Avalo to Present at the Oppenheimer Novel Targets in Immunology Summit • GlobeNewswire Inc. • 06/17/2024 11:30:00 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 06/07/2024 11:01:10 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 06/06/2024 08:03:22 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 06/03/2024 11:20:28 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 08:01:22 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 05/13/2024 04:38:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 11:33:15 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 11:30:59 AM
- Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 05/13/2024 11:30:00 AM
- Avalo Therapeutics Appoints Biotech Leaders to Board of Directors • GlobeNewswire Inc. • 04/02/2024 11:00:00 AM
- Avalo Reports 2023 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 03/29/2024 08:01:00 PM
- Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million • GlobeNewswire Inc. • 03/27/2024 08:01:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/15/2024 02:13:42 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 03:02:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 09:01:27 PM
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM
Kona Gold Beverage Significantly Reduces Debt from Multiple Holders • KGKG • Jul 31, 2024 9:00 AM
Avant Technologies Opens Equity Line with GHS Investments as Company Explores Expansion into Additional Technologies • AVAI • Jul 30, 2024 8:00 AM
ELEMENT79 GOLD CORP PROVIDES UPDATE ON CHACHAS COMMUNITY CHARTER AND REVENUE GENERATION, M&A ACTIVITIES • ELMGF • Jul 30, 2024 8:00 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM